A

Amgen

Makes biotech medicines for serious illnesses

Grad Intern - R&D Translational Immunology

Translational Research & Bench BiologyConfirmed live in the last 24 hours
Internship · Summer 2027South San Francisco, CA, USA$35.34 - $41.20 /hr

About the Job

Requirements

  • The applicant must be at least 18 years old.
  • The applicant must have graduated with a bachelor's degree from an accredited college or university.
  • The applicant must be currently enrolled in an accredited MBA, Master's, PharmD, or PhD program and have completed the first year of that program before the internship starts.
  • The applicant must be available to work a full-time schedule.
  • The applicant must remain enrolled at an accredited college or university following the internship program or co-op.
  • The student must be located in the United States for the duration of the internship program.
  • The applicant must have foundational training in immunology and demonstrated expertise in cellular immunology, primary cell culture techniques, and flow cytometry.
  • The applicant must have hands-on experience with 2D and 3D primary cell culture and microscopic evaluation.
  • The applicant must be able to contribute to project design and solve complex scientific challenges.

Responsibilities

  • Develop and implement cell-based in vitro hematopoietic models to investigate immunological safety risks of drug candidates in the Oncology pipeline.
  • Develop and implement mechanism-based in vitro New Approach Methodologies to evaluate hematotoxicities and contribute to assay design through literature-based evaluations.
  • Maintain, differentiate, and analyze various primary immune cell types in 2D and 3D cultures.
  • Apply immunological techniques, including multiparametric flow cytometry and ELISA, MSD, and Luminex, to assess toxicities.
  • Present research findings to the broader Translational Safety and Risk Sciences team.

Desired Qualifications

  • A degree concentration in immunology, cell biology, oncology, or toxicology.

About the Company

Amgen

Makes biotech medicines for serious illnesses

Amgen develops and makes biologic medicines, which are drugs built from proteins and antibodies grown in living cells, for serious conditions such as heart disease, cancer, and bone loss. Its anemia drug Epogen, approved in 1989, became one of the biotechnology industry's first blockbuster medicines. Amgen grows these drugs in large tanks called bioreactors, and its products include the cholesterol drug Repatha, the bone-building drug Evenity, and the severe asthma drug Tezspire. It earns money by selling these medicines, mostly through large drug wholesalers that supply hospitals and pharmacies. Amgen was founded in 1980 and is based in Thousand Oaks, California.

Company size
10,001+
Company stage
IPO
Headquarters
Thousand Oaks, CA
Founded
1980

Recently Posted Jobs

Explore more opportunities at Amgen

See more jobs